Monitoring and Predicting Breast Cancer Neoadjuvant Chemotherapy Response Using Diffuse Optical Spectroscopic Imaging

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01257932
Recruitment Status : Withdrawn (According to the NIH definition of clinical trial studies, this study does not meet requirement to be a clinical trial study.)
First Posted : December 10, 2010
Last Update Posted : February 6, 2018
American College of Radiology Imaging Network
Massachusetts General Hospital
University of Pennsylvania
Dartmouth-Hitchcock Medical Center
University of San Francisco
M.D. Anderson Cancer Center
Boston University
Beckman Laser Institute University of California Irvine
Information provided by (Responsible Party):
Beckman Laser Institute and Medical Center, University of California, Irvine

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Actual Primary Completion Date : October 2013
  Actual Study Completion Date : October 2013